or
forgot password

    • cancer clinical trials in anchorage, AK

    • S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Cancer Center at Providence Alaska Medical Center
    Anchorage, Alaska 99519-6604
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Hormone-Refractory Prostate Cancer, Prostatic Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Alaska Oncology and Hematology
    Anchorage, Alaska 99508
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostatic Neoplasms
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Cancer Center at Providence Alaska Medical Center
    Pancreatic Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Lung Cancer, Non-small-cell Lung Carcinoma
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Esophageal Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Breast Cancer
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Lymphoma
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Alaska Cancer Research & Education Center
    Anchorage, Alaska 99508
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lung Cancer
    S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lung Cancer
    The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostate Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Head and Neck Cancer
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Anchorage, Alaska 99508
    Small Cell Lung Cancer
    Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Alaska Oncology and Hematology LLC
    Anchorage, Alaska 99508
    Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Alaska Heart Institute
    Anchorage, Alaska 99508
    Atrial Fibrillation, Atrial Flutter
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Prostate Cancer
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Alaska Cancer Research and Education Center
    Anchorage, Alaska 99508
    Cachexia
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840068
    Anchorage, Alaska 99508
    Urinary Bladder Neoplasms
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8569
    Anchorage, Alaska 99508
    Prostate Cancer
    Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
    Alaska Urological Association
    Anchorage, Alaska 99508
    Prostate Cancer
    SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lymphoma
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Providence Cancer Center
    Anchorage, Alaska 99508
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lymphoma
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium